Recursion Pharmaceuticals
clinical phase trial initiated in enrollment criteria outcome measures trial update sycamore underway | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
95 of 143
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
March 2023
phase clinical trial to generate proof of concept and path to pivotal trial | Aeglea BioTherapeutics
BioNTech
Results
May 2020
global clinical development program ongoing prime boost vaccine prime only vaccine | BioNTech
MaxCyte
Investor Presentation
August 2023
enabled active clinical trials | MaxCyte
MindMed
Investor Presentation
April 2021
develop phase a clinical trial | MindMed
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io